Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to one of our industry newsletters.

Recently Added

1/17/2020
BreakingFundingOphthalmicPharmaRetina
Apellis Raises $404.2 Million in Public Offering

Apellis Pharmaceuticals, now of Waltham, Massachusetts, announced Jan. 14 that it had raised $404.2 million in gross proceeds from an underwritten public offering of common stock, including the ful...

1/17/2020
BreakingGene TherapyOphthalmicRegulationRetina
FDA Lifts Clinical Hold on Regenxbio’s Gene Therapy Candidate for Wet AMD

Gene therapy company Regenxbio reported Jan. 9 that the FDA has removed a partial clinical hold on its Phase I/IIa trial of subretinal delivery of RGX-314 for wet age-related macular degeneration w...

1/17/2020
BreakingCataractOphthalmicRegulationSurgical
STAAR Gains Supplemental Lens Approval for EVO Visian ICL in Post-Cataract Patients

STAAR Surgical has gained CE marking for use of its implantable collamer lenses (ICL) as a supplemental or “piggyback” lens in post-cataract surgery patients, the company announced Jan. 13. A suppl...

1/17/2020
BreakingDealsOphthalmicPharmaRetina
Exonate Teams with Janssen to Develop Eye Drop for Wet AMD, DME

Exonate, of Cambridge, England, has entered into a strategic collaboration agreement with Janssen Pharmaceuticals to develop an eye drop treatment for retinal vascular diseases, the company announc...

1/17/2020
BreakingDiagnosticOphthalmicRegulation
CPT Codes Established for Home OCT Use

The American Medical Association’s Current Procedural Terminology (CPT) panel has established three new Category III codes (0604T, 0605T, 0606T) to report patient-initiated remote retinal optical c...

1/17/2020
NewsletterOrthopedic
Medtronic Issues Field Safety Notice for Mazor X Positioner

Medtronic issued a field safety notice Jan. 7 for its Mazor X surgical system with Positioner Type II latching device. The positioner, which locks onto the OR table through a pneumatic system, may ...

1/17/2020
NewsletterOrthopedic
Exactech Names Johnson New CEO

Exactech, a Florida-based orthopedic implant company with solutions for extremities, knees, and hips, announced Jan. 7 that Darin Johnson will be taking David Petty’s place as president and CEO. Pe...

1/17/2020
BreakingDealsOphthalmicPharmaRetina
Coherus Acquires Commercial Rights for Avastin Biosimilar in the US

Coherus BioSciences has entered into a licensing agreement with Innovent Biologics of China to commercialize Innovent’s biosimilar candidate to Avastin (bevacizumab) in the US and Canada, the compa...

1/17/2020
NewsletterOrthopedic
Bone Biologics’ rhNELL-1 Promotes Bone Formation in Preclinical Study

rhNELL-1, a recombinant human protein growth factor, effectively promoted bone formation in a pre-clinical ovine study, Bone Biologics announced Jan. 7. The treatment was well-tolerated by the subj...

1/17/2020
NewsletterOrthopedic
FTC Takes a Closer Look at Proposed Stryker, Wright Merger

The US Federal Trade Commission (FTC) is taking a closer look at the proposed merger between Stryker and Wright Medical; the commission’s concerns were outlined in a Jan. 2 SEC filing. Stryker anno...

1/17/2020
NewsletterOrthopedic
Zebra Medical Vision Signs Co-Development and Commercialization Agreement With DePuy

Israel-based Zebra Medical Vision announced Dec. 19 that is has entered an agreement with DePuy Synthes to integrate its artificial intelligence with orthopedic imaging. Zebra’s deep-learning techn...

1/17/2020
BreakingGlaucomaOphthalmicPharma
Bausch + Lomb Gains Approval for Vyzulta in Mexico, Hong Kong, Argentina

Bausch + Lomb has received approval for Vyzulta (latanoprostene bunod ophthalmic solution 0.024%) in Mexico, Hong Kong, and Argentina for the reduction of IOP in patients with open-angle glaucoma o...

Past News Stories

1/17/2020
BreakingFundingOphthalmic
EyeGate Raises $5 Million in Registered Direct Offering

EyeGate Pharmaceuticals has completed a registered direct offering with gross proceeds of $5 million, the company announced Jan. 3. Priced at-the-market under Nasdaq, the 500 thousand shares of Eye...

1/17/2020
BreakingDeviceFundingLow VisionOphthalmic
Nunaps Nets $4.2 Million in Series A Financing

Nunaps announced Jan. 5 that it had closed on $4.2 million in Series A financing. The round was led by Company K Partners, KTB Network, and K2 Investment Partners. The Korean company has recently i...

1/17/2020
BreakingFundingGene TherapyOphthalmic
Eyevensys Closes $30 Million Series B Financing

Eyevensys announced on Jan. 8 that it had completed a $30 million Series B financing. The round was led by Boehringer Ingelheim Venture Fund and included existing investors Pontifax, Bpifrance, Cap...

1/17/2020
BreakingDry EyeFundingOphthalmic
Tarsus Pharmaceuticals Raises $60 Million for Demodex Blepharitis Drug Trial

Tarsus Pharmaceuticals announced Jan. 8 the completion of $60 million in Series B financing. The Irvine, California, company will use the funds to initiate a Phase IIb/III trial in the US of its le...

1/17/2020
BreakingFundingOphthalmicRetina
LumiThera Raises $10 Million in Second Tranche of Series C Financing

Photobiomodulation company LumiThera announced Jan. 13 that it had raised $10 million in the second tranche of its Series C round of financing. The Seattle company will use the funds to support fur...

1/15/2020
NewsletterOrthopedic
CMS Policy Change Allows Outpatient Joint Replacement Surgery

Policy updates by the Centers for Medicare and Medicaid Services (CMS) may trigger vast changes within the orthopedic industry. The CMS is now providing reimbursement for joint replacement in ambul...

1/15/2020
NewsletterOrthopedic
Over $25M in Orthopedic Deals Between Nov. 15 and Dec. 15

Three noteworthy deals took place between Nov. 15 and Dec. 15; the largest was Synaptive Medical’s $25 million equity investment to expand the availability of its cranial and spinal products. Addit...

1/15/2020
NewsletterOrthopedic
Orthopedic US FDA 510(k) Clearances

During the past month, 49 orthopedic devices were cleared by the FDA through the 510(k) pathway. Eighteen of the devices are spine implants. Six are for fixation, including five rod and screw syste...

1/15/2020
NewsletterOrthopedic
DMSO-Free Cellular Allograft May Be Safer and More Effective

Scendia Biologics, formed by Ryan Philips in Orlando, Florida, was originally a tissue bank for the central Florida hospital and surgery center biologics market. The company has grown to offer a wi...

1/15/2020
NewsletterOrthopedic
2019 in Review

Market Scope’s top five stories for 2019 cover the biggest trends in orthopedics. We tracked these trends throughout the year by examining clinical research, attending major industry meetings, and ...

1/15/2020
NewsletterOrthopedic
Medical Device Tax Is Permanently Repealed in the United States

The much-maligned medical device excise tax was repealed Dec. 20 in one of two US spending bills signed by the president. The repeal, spelled out in Section 501 of H.R. 1865, began in January 2020....

1/14/2020
InterbodyOrthopedicPress ReleaseSurgical
Developments in Spinal Fusion Buoy Interbody Cage Costs in Wealthy Regions

Spinal fusion is one of the most common surgical treatments for back pain, with an estimated annual total of 1.5 million procedures worldwide. These procedures use an estimated 1.8 million interbod...

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2020 Market Scope, LLC. All Rights reserved.